Noninfectious uveitis, immunosuppressive drug therapy can significantly increase the risk of endophthalmitis after cataract surgery.

We found a 7.3-fold lower ratio of endophthalmitis after cataract surgery in the group that received moxifloxacin during surgery. Although this decrease is higher than other comparable studies, it may ...

Over-the-counter medications can have easily overlooked impacts on eye health if not used appropriately, according to a ...

Optometrists have an important part to play in the management of patients with long COVID, according to a speaker at ...

The FDA has approved a new drug for sight-robbing disease geographic atrophy from Astellas, just a few weeks after the company bought its developer Iveric Bio for $5.9 billion.

Roche's Genentech unit has won FDA approval for Susvimo, an implant for eyesight-robbing disease wet age-related macular degeneration (AMD) that gives patients an alternative to regular injections ...

At the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) meeting held in Los Angeles, the top paper ...

Sonia H. Yoo, MD, a cornea, cataract, and refractive surgery specialist and a member of the planning committee for the EnVision Summit, highlights a session focused on the latest advancements in lens ...